Mental Health News and Research

Latest Mental Health News and Research

NeuroDerm commences enrollment in ND0801 Phase 2a clinical study of ADD/ADHD in adults

NeuroDerm, Ltd. announced today that patient enrollment has begun in a Phase 2a clinical study of ND0801, a new product for the treatment of Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder (ADD/ADHD) in adults. ND0801, based on a new, proprietary combination with nicotinic actions, is being developed as a dermal patch and will be evaluated for the treatment of cognitive impairment in several disorders including Alzheimer's disease, schizophrenia and advanced Parkinson's disease, among others.

9 Nov 2010

Stressed out Americans

The American Psychological Association’s (APA) have released the results of the 2010 Stress in America survey that shows up the long-term impact that chronic stress could have on physical and emotional health and the health of the families. The survey was conducted by Harris Interactive in August 2010. It showed some worrying trends of stress among parents as well as children.

9 Nov 2010

Study finds lack of medication adherence among people with RA and lupus

People with rheumatic diseases don't take their medication on a regular basis, and this leads to poor outcomes in their disease treatment, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.

9 Nov 2010

Study says looking older does not necessarily point to poor health

Even though most adults want to avoid looking older than their actual age, research led by St. Michael's Hospital shows that looking older does not necessarily point to poor health. The study found that a person needed to look at least 10 years older than their actual age before assumptions about their health could be made.

9 Nov 2010

Excessive texting and networking raise new health concerns for teens

Texting while driving can be a deadly combination for teenagers. Yet, new data released today reveal that the dangers of excessive texting among teens are not limited to the road. Hyper-texting and hyper-networking are now giving rise to a new health risk category for this age group.

9 Nov 2010

Research report on current and evolving technologies in drug delivery

The drug delivery market is a rapidly evolving force in the pharmaceutical industry. Within this segment injectables have a significant role to play at present with the increasing use of proteins and peptides.

9 Nov 2010

Childhood abuse increases risk of type 2 diabetes in women: Study

A new study of nearly 70,000 women found a clear association between abuse in childhood and adolescence and the risk of type 2 diabetes in adult women.

9 Nov 2010

Positive adult interactions during childhood guard against personality disorders later in life

Learning a hobby or other complex task in childhood with assistance from a trusted adult may help guard against the emergence of a personality disorder (PD) later on in life, reports a study in the current issue of the journal, Development and Psychopathology.

9 Nov 2010

Duke focuses on community health in N.C.; Baltimore mental health agency's practices raise questions; Mass. clinic’s efforts to curb diabetes highlighted

The Washington Post reports on Duke University's experiment with community health centers Duke University has been focusing closer attention on the neighborhood that surrounds it by forming a partnership with Durham's Federally Qualified Health Center.

9 Nov 2010

Children of deployed parents more likely to suffer mental health problems

The New York Times: "Young children in military families are about 10 percent more likely to see a doctor for a mental difficulty when a parent is deployed than when the parent is home, researchers are reporting Monday in the most comprehensive study to date of such families' use of health insurance during wartime."

9 Nov 2010

Thirteen myths about arthritis and rheumatic disease

A diagnosis of arthritis or another rheumatic disease can cause someone to feel anxious and even a little overwhelmed. Being a knowledgeable and empowered patient can help alleviate some of those feelings, and being able to navigate through the many misconceptions about arthritis and rheumatic diseases is vitally important.

8 Nov 2010

Raptor initiates dosing in DR Cysteamine Phase 2 clinical trial for Huntington's Disease

Raptor Pharmaceutical Corp., today announced that the first patient has been dosed in its Phase 2 clinical trial of DR Cysteamine for the potential treatment of Huntington's Disease. The Phase 2 clinical trial is being conducted under a previously announced collaboration agreement with The Centre Hospitalier Universitaire d'Angers ("CHU d'Angers"), which has commenced enrolling patients at eight clinical sites throughout France.

8 Nov 2010

First Edition: November 8, 2010

Today's health policy headlines include more post-mortem reports about the health law's impact on the election.

8 Nov 2010

TransTech Pharma, High Point receive $1.96 million grants under QTDP program

TransTech Pharma, Inc. and High Point Pharmaceuticals, LLC. today announced that they have been awarded cash grants totaling $1.96 million under the U.S. Government's Qualifying Therapeutic Discovery Project program.

8 Nov 2010

22nd Century awarded $244,000 QTDP program grant

22nd Century Limited, LLC, a company focused on smoking cessation and tobacco harm reduction products, announced that it has been awarded $244,000 in grant funding as part of the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.

8 Nov 2010

Risk pools, drug prices and other issues in health law implementation

A health law program that directs $5 billion for coverage of otherwise uninsurable people through state-run high-risk insurance pools has attracted only 8,011 people according to health department enrollment figures, The New York Times reports. That's a paucity compared to the hundreds of thousands of people government actuaries predicted would flock to the program causing it to run out of money too early.

8 Nov 2010

FDA approves Cymbalta for treatment of chronic musculoskeletal pain

The U.S. Food and Drug Administration today approved Cymbalta (duloxetine hydrochloride) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain. Cymbalta was first used to treat major depressive disorder in 2004.

8 Nov 2010

Deletion of 17q12 chromosomal region increases risk factor for ASD, schizophrenia

Researchers have identified the deletion of a genomic region on chromosome 17 as a significant risk factor for autism spectrum disorders (ASD) and schizophrenia. A mutation of one of the genes in the deleted interval already is a known cause of renal cysts and diabetes syndrome (RCAD).

8 Nov 2010

Mass. focuses on containing health care costs, Gov. Schwarzenegger seeks to expand coverage of uninsured in Calif.

While the White House seems destined to spend the next two years fending off attacks on President Obama's health care law, the administration of Governor Deval Patrick of Massachusetts will push forward with the next stage of health care overhaul: trying to contain the escalating costs of medical care.

7 Nov 2010

New findings on mitochondrial haplogroups associated with successful aging to be presented at ASHG Meeting

Thousands of the world's top scientists and clinicians in the human genetics field will convene to present their latest research findings at the American Society of Human Genetics (ASHG) 60th Annual Meeting, on November 2-6, 2010, in Washington, D.C.

4 Nov 2010

Mental Health News and Research

Latest Mental Health News and Research

NeuroDerm commences enrollment in ND0801 Phase 2a clinical study of ADD/ADHD in adults

Stressed out Americans

Study finds lack of medication adherence among people with RA and lupus

Study says looking older does not necessarily point to poor health

Excessive texting and networking raise new health concerns for teens

Research report on current and evolving technologies in drug delivery

Childhood abuse increases risk of type 2 diabetes in women: Study

Positive adult interactions during childhood guard against personality disorders later in life

Duke focuses on community health in N.C.; Baltimore mental health agency's practices raise questions; Mass. clinic’s efforts to curb diabetes highlighted

Children of deployed parents more likely to suffer mental health problems

Thirteen myths about arthritis and rheumatic disease

Raptor initiates dosing in DR Cysteamine Phase 2 clinical trial for Huntington's Disease

First Edition: November 8, 2010

TransTech Pharma, High Point receive $1.96 million grants under QTDP program

22nd Century awarded $244,000 QTDP program grant

Risk pools, drug prices and other issues in health law implementation

FDA approves Cymbalta for treatment of chronic musculoskeletal pain

Deletion of 17q12 chromosomal region increases risk factor for ASD, schizophrenia

Mass. focuses on containing health care costs, Gov. Schwarzenegger seeks to expand coverage of uninsured in Calif.

New findings on mitochondrial haplogroups associated with successful aging to be presented at ASHG Meeting

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Mental Health News and Research

Latest Mental Health News and Research

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in